Bioanalytical Method Validation—A Revisit with a Decade of Progress

被引：1506
作者：
Vinod P. Shah
Kamal K. Midha
John W. A. Findlay
Howard M. Hill
James D. Hulse
Iain J. McGilveray
Gordon McKay
Krys J. Miller
Rabindra N. Patnaik
Mark L. Powell
Alfred Tonelli
C. T. Viswanathan
Avraham Yacobi
机构：
[1] Food and Drug Administration,Center for Drug Evaluation and Research
[2] University of Saskatchewan,undefined
[3] Saskatoon,undefined
[4] Pharmacia Corporation,undefined
[5] Huntingdon Life Sciences,undefined
[6] Huntingdon,undefined
[7] MDS Harris,undefined
[8] McGilveray Pharmacon Inc.,undefined
[9] Amgen,undefined
[10] Bristol-Meyers Squibb,undefined
[11] Inc.,undefined
[12] Purdue Pharma,undefined
[13] LP,undefined
[14] Taro Pharmaceuticals USA INC.,undefined
来源：
Pharmaceutical Research | 2000年 / 17卷 / 12期
关键词：
Method Validation; Bioanalytical Method Validation;
D O I：
10.1023/A:1007669411738
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1551 / 1557
页数：6
相关论文
共 22 条
  • [1] Findlay J. W. A.(1995)Validation of immunoassay for macromolecules from biotechnology International Conference on Harmonization: Guideline on validation of analytical procedures: methodology, Federal Register 60 11200-11262
  • [2] Das I.(1997)Validation of immunoassays for bioanalysis: A pharmaceutical industry perspective International Conference on Harmonization: Guideline on validation of analytical procedures: definitions and terminology, Federal Register 62 27464-27467
  • [3] Findlay J. W. A.(1998)Validation of bioanalytical chromatographic methods J. Clin. Ligand Assay. 21 249-253
  • [4] Smith W. C.(2000)Validation of bioanalytical methods J. Pharm. Biomed. Anal. 21 1249-1273
  • [5] Lee W.(1998)An assessment of the 4-6-20 rule of acceptance of analytical runs in bioavailability, bioequivalence, and pharmacokinetic studies J. Pharm. Biomed. Anal. 17 193-218
  • [6] Nordblom G. D.(1991)Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic Studies (Conference report) Pharm. Res. 8 421-426
  • [7] Das I.(1994)Rational experimental design for bioanalytical methods validation. Illustration using an assay method for total captopril in plasma Pharm. Res. 11 556-560
  • [8] DeSilva B. S.(1992)undefined Pharm Res. 9 588-592
  • [9] Khan M. N.(1996)undefined J. Chromatography 730 381-394
  • [10] Bowsher R. R.(undefined)undefined undefined undefined undefined-undefined
123